|
Median age (range) (y)
|
52 (23–74)
|
|
Male/female [number (%)]
|
29 (55)/24 (45)
|
|
ECOG performance status [number (%)]
|
|
0
|
7 (13)
|
|
1
|
35 (66)
|
|
2
|
11 (21)
|
|
Primary tumor site [number (%)]
|
|
Colon
|
23 (40)
|
|
Rectosigmoid
|
21 (36)
|
|
Rectum
|
9(15)
|
|
Prior surgery for primary tumor [number (%)]
|
29 (55)
|
|
Prior adjuvant chemotherapy [number (%)]
|
6 (11)
|
|
Prior radiotherapy [number (%)]
|
0
|
|
Number of metastasis sites [number (%)]
|
|
Single
|
22 (42)
|
|
Multiple sites
|
31 (58)
|
|
Metastasis sites [number (%)]
|
|
Liver
|
35 (66.0)
|
|
Lung
|
22 (41.5)
|
|
Lymph nodes
|
21 (39.6)
|
|
Peritoneum
|
14 (26.4)
|
|
K-ras [number (%)]
|
|
Wild-type
|
20 (37.0)
|
|
Mutated
|
20 (37.0)
|
|
Unknown
|
13 (26.0)
|
